Gedeon Richter makes Mexican acquisition
This article was originally published in Scrip
Executive Summary
Hungarian pharma group Gedeon Richter has acquired the majority of Mexican pharmaceutical company DNA Pharmaceuticals with plans to buy the company outright within three years. This is Richter's second Latin American deal this month: it has already acquired a 51% stake in Next Pharma of Brazil.